A lever-release version of the conditioned avoidance response paradigm: Effects of haloperidol, clozapine, sulpiride, and BMY-14802

This publication has 28 references indexed in Scilit:

• Repeated testing of rats markedly enhances the duration of effects induced by haloperidol on treadmill locomotion, catalepsy, and a conditioned avoidance response
  Pharmacology Biochemistry and Behavior, 1987
• Evidence that the potential antipsychotic agent rimcazole (BW 234U) is a specific, competitive antagonist of sigma sites in brain
  Life Sciences, 1986
• Pharmacological and anatomical analysis of fear conditioning using the fear-potentiated startle paradigm.
  Behavioral Neuroscience, 1986
• Pharmacological Specificity of Conditioned Avoidance Response Inhibition in Rats: Inhibition by Neuroleptics and Correlation to Dopamine Receptor Blockade
  Acta Pharmacologica et Toxicologica, 1982
• Antipsychotic Drugs, Neurotransmitters, and Schizophrenia
  American Journal of Psychiatry, 1978
• Neuropharmacological and behavioral evaluation of prostaglandin E2 and 11-thiol-11-desoxy prostaglandin E2 in the mouse and rat
  Psychopharmacology, 1978
• Differential effects of neuroleptic and other psychotropic agents on acquisition of avoidance in rats
  Life Sciences, 1976
• Haloperidol-induced disruption of conditioned avoidance responding: Attenuation by prior training or by anticholinergic drugs
  European Journal of Pharmacology, 1975
• Action of a new psychotropic drug (Sulpiride) on avoidance behavior in rats
  Psychopharmacology, 1974
• BEHAVIORAL EFFECTS OF SOME PSYCHOPHARMACOLOGICAL AGENTS
  Annals of the New York Academy of Sciences, 1957